CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 30 enrolled
Drug / intervention
Bupivacaine +4 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02973958
NCT02973958Phase 1Completed
CompareCT.gov

A Pilot Study Evaluating Pain Outcomes of Ketorolac Administration in Children Undergoing Circumcision

Alberta Children's Hospital·interventional·Posted Nov 28, 2016·Updated Jun 29, 2018

In Brief

A Phase 1 clinical trial evaluating Bupivacaine, Sevoflurane, and 3 other interventions for Pain, Postoperative and 3 related conditions. Completed, enrolled 30 participants across 1 site.

Detailed Summary

Circumcision is the most common surgical procedure performed by Pediatric Urologists. Ketorolac has been shown to have an efficacy similar to morphine in multi-modal analgesic regimens without the commonly associated adverse effects. This study aims to see if giving ketorolac during the operation will result in better pain control. We hypothesize that ketorolac will result in pain control similar to morphine with a lower incidence of side effects such as nausea and vomiting.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative, Phimosis, Paraphimosis, Balanitis
CountriesCanada
Collaborators--

Timeline

Phase 1CompletedFinished
2017201820192020202120222023202420252026
First PostedNov 28, 2016
Enrollment StartFeb 1, 2017
Primary CompletionJun 28, 2018
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 9.6 years ago

Interventions

Bupivacainedrug

See active comparator description

Sevofluranedrug

See active comparator description

Acetaminophendrug

See active comparator description

Ibuprofendrug

See active comparator description

Ketorolacdrug

See experimental arm description